Companion Diagnostics: Biomarker Platforms Enabling Precision Medicine
12:06 ET
NEW YORK, Nov. 19, 2018 /PRNewswire/ -- Unveiling One of the Most Promising Fields of Therapeutic Technology Synergy
Both predictive and prognostic biomarkers constitutes an central element in each and every targeted oncology drug discovery and development program.Breakthrough technologies allowing leveraging biomarkers for oncology are paving the way of personalized medicine and precision oncology.
Read the full report: https://www.reportlinker.com/p05623085
Indeed, oncology biomarkers provide the clinical community with the opportunity to offer individualized therapies and health programs. Furthermore, oncology biomarkers enable to get critical information about the mechanism of action of a drug or target, to profoundly study carcinogenesis process, and to match patient characteristics specifically to the most appropriate treatment.
Read the full report: https://www.reportlinker.com/p05623085
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker